Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hyperlipidemias/adipositas
Der Link wird in der Zwischenablage gespeichert
Seite 1 von 642 Ergebnisse
Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2009/004301, filed Jul. 31, 2009, which claims benefit of Korean Patent Applications 10-2008-0075659, filed Aug. 1, 2008, and 10-2009-0032463, filed
Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2010/008944, filed Dec. 14, 2010, which claims benefit of Korean Patent Application No. 10-2010-0004901, filed Jan. 19, 2010.
FIELD OF THE
Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of PCT International Application PCT/KR2011/010161, filed Dec. 27, 2011, which claims priority from Korean Patent Application 10-2011-0010585, filed Feb. 7, 2011.
TECHNICAL FIELD
The
Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2009/007905, filed Dec. 29, 2009, which claims benefit of Korean Patent Application 10-2009-0022937, filed Mar. 18, 2009.
TECHNICAL FIELD
The
Composition of wood ear, shiitake, hawthorn fruit, roselle, celery and fruit of chinese plum for treatment and/or prevention of hyperlipidemia, atherogenesis and obesity
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
The invention provides a water extract of Yan-Sheng-Yin (YSY), a Chinese natural dietary supplement for health promotion, comprised entirely of natural foods and a preparation comprising the same. The invention also provides a method for treatment and/or prevention of
Composition for the treatment of obesity and hyperlipidemia
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS REFERENCE TO PRIOR APPLICATIONS
This application claims the benefit of PCT International Application No.
PCT/MX2005/000058, filed Jul. 18, 2005, which claims priority from Mexican Patent Application No. PA/a/2004/0010692, filed Oct. 28, 2004, the entire disclosures of which are incorporated by
Use of a statin compound as local drug for treating obesity, diabetes, hypertension and hyperlipemia
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
The present invention relates to medicine technology, and more specifically, it relates to a new use of HMG-CoA reductase inhibitor (statins compound) locally used for prevention and treatment of diabetes, obesity, hypertension, hyperlipidemia, artheroslerosis, cardiovascular
Use of a statin compound as topical drug for treating obesity, diabetes, hypertension and hyperlipemia
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This is a U.S. National Phase entry based on PCT/CN2013/001429 filed Nov. 22, 2013, which respectively claiming priority to Chinese patent application 20120512630.8 filed Nov. 23, 2012 and Chinese patent application 201310426327.0 filed Sep. 18, 2013.
FIELD OF THE INVENTION
The present invention
Composition for repression of hyperlipidemia and obesity through suppression of intestinal cholesterol absorption
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national phase, pursuant to 35 U.S.C. .sctn.371, of PCT international application Ser. No. PCT/KR2011/003007, filed Apr. 25, 2011, designation the United States and published in Korean on Dec. 15, 2011 as publication WO2011/155705.
Implantable electroacupuncture system and method for treating dyslipidemia and obesity
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND INFORMATION
An estimated 1.1 billion adults worldwide are overweight or obese, one hundred thirty million of whom are adults in the United States. See, Haslam, D., Sattar, N., & Lean, M. (2006). Obesity--time to wake up. Bmj, 333(7569), 640-642; Flegal, K. M., Carroll, M. D., Ogden,
Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to pyrrolidinone derivatives of the formula I
##STR00001##
in which R.sup.1a, R.sup.1b, R.sup.1c, R.sup.2a, R.sup.2b, R.sup.2c, X, Y.sup.1 and Y.sup.2 are defined as indicated below. The pyrrolidinone derivatives I are GPR119 modulators and useful for the prevention
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims priority benefit to EP Application No. 17305189.7, filed Feb. 21, 2017, the disclosure of which is herein incorporated by reference in its entirety.
DETAILED DESCRIPTION
The present disclosure relates to compounds of formula
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to isoindolinone compounds of the formula I
##STR00001## in which A, X, R1b, R1c, R2a, R2b, R2c, R3, R4, R30, Y and Z are defined as indicated below. The isoindolinone compounds I are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity,
Implantable electroacupuncture system and method for treating dyslipidemia and obesity
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND INFORMATION
An estimated 1.1 billion adults worldwide are overweight or obese, one hundred thirty million of whom are adults in the United States. See, Haslam, D., Sattar, N., & Lean, M. (2006). Obesity--time to wake up. Bmj, 333(7569) 640-642; Flegal, K. M., Carroll, M. D., Ogden, C.
11-.beta.-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
The present invention relates to inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase Type I (11.beta.-HSD-1 or HSD-1), and methods of treatment using such compounds. The compounds are useful for the treatment of diabetes, such as non-insulin dependent type 2 diabetes
Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird
- Arbeitet in 55 Sprachen
- Von der Wissenschaft unterstützte Kräuterkuren
- Kräutererkennung durch Bild
- Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
- Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
- Suchen Sie nach Heilkräutern nach ihrer Wirkung
- Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden
Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen
